Key points are not available for this paper at this time.
Long-term, disease-free breast cancer survivors reported high levels of functioning and QOL many years after primary treatment. However, past systemic adjuvant treatment was associated with poorer functioning on several dimensions of QOL. This information may be useful to patients and physicians who are engaging in discussion of the risks and benefits of systemic adjuvant therapy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Peter Ganz
University of Pisa
JNCI Journal of the National Cancer Institute
University of California, Los Angeles
Building similarity graph...
Analyzing shared references across papers
Loading...
Peter Ganz (Wed,) studied this question.
synapsesocial.com/papers/69df4625de200760a8614d27 — DOI: https://doi.org/10.1093/jnci/94.1.39